Considering SUMO2/3 is known to be a dynamic modifier, and canonically linked to cell-cycle regulation, replication, and the DNA damage response52, our observations suggest that rapidly and ever-dividing cancer cells rely on the SUMOylation pathway to maintain their genomic integrity. This evidence concerns the gene SUMO2 and cancer.